INS and type 2 diabetes mellitus: Crawford et al.,53 in a 12-week observational study of 150 T2D adults treated with nonintensive insulin therapy (NIIT), evaluated the effects of rtCGM use on key glycemic metrics.53 Patients received no additional education beyond standard of care.